Where can I buy BDX stock?
Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What are Becton Dickinson and's stock's price targets for next year?
7 brokerages have issued twelve-month price targets for Becton, Dickinson and's stock. Their forecasts range from $250.00 to $300.00. On average, they expect Becton, Dickinson and's stock price to reach $272.43 in the next year. This suggests a possible upside of 4.0% from the stock's current price.
What did BDX acquire from CubeX?
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired the Medical Business assets of CUBEX LLC, which is a privately-held company that develops cloud-based software offerings for advanced medication management.
What is the percentage difference between bdcom and bdlamps?
BDCOM 27.90 0.30 1.09% BDFINANCE 66.70 0.10 0.15% BDLAMPS 231.50 7.70 3.44% BDTHAI 28.60 -0.70 -2.39% BDWELDING 23.70 -0.70 -2.87%
See more
Is Becton Dickinson stock a buy?
(NYSE: BDX) Becton Dickinson & Co's forecast annual earnings growth rate of 28.56% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 21.28%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 15.64%.
Is BD publicly traded?
Since becoming publicly held in 1962, BD has paid regular quarterly dividends and has also declared periodic dividend increases.
Is BD a Fortune 500 company?
BD is ranked #177 in the 2021 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2020.
What does BD company do?
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories.
What is BD valuation?
What is the BD ranked?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents.
Where is BD located?
BD is ranked #195 in the 2019 Fortune 500 list. In October 2014, the company agreed to acquire CareFusion for a price of $12.2 billion in cash and stock. In April 2017, Becton Dickinson agreed to acquire C. R. Bard for $24 billion.
Who is BD Pharmaceuticals?
BD also provides consulting and analytics services in certain geographies. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 70,000 people in more than 50 countries throughout the world.
What is BD medical?
The company's customers include health care institutions, science researchers, clinical laboratories, the pharmaceutical industry , and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles.
New York Stock Exchange
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Environmental, Social, and Governance Rating
Becton, Dickinson makes all sorts of medical devices and instruments, including scalpels, syringes, and diagnostic equipment.
Business Summary
"A" score indicates excellent relative ESG performance and a high degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
1.1 Analyst's Opinion
Becton, Dickinson makes all sorts of medical devices and instruments, including scalpels, syringes, and diagnostic equipment.
Is Becton, Dickinson and a buy right now?
Becton, Dickinson and has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.
How has Becton, Dickinson and's stock been impacted by COVID-19?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton, Dickinson and in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Becton, Dickinson and stock.
When is Becton, Dickinson and's next earnings date?
Becton, Dickinson and's stock was trading at $231.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BDX stock has increased by 15.8% and is now trading at $268.66. View which stocks have been most impacted by COVID-19.
How were Becton, Dickinson and's earnings last quarter?
Becton, Dickinson and is scheduled to release its next quarterly earnings announcement on Wednesday, May 4th 2022. View our earnings forecast for Becton, Dickinson and.
How often does Becton, Dickinson and pay dividends? What is the dividend yield for Becton, Dickinson and?
Becton, Dickinson and Company (NYSE:BDX) announced its quarterly earnings data on Thursday, February, 3rd. The medical instruments supplier reported $3.64 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.85 by $0.79.
Is Becton, Dickinson and a good dividend stock?
Becton, Dickinson and declared a quarterly dividend on Tuesday, January 25th. Shareholders of record on Thursday, March 10th will be given a dividend of $0.87 per share on Thursday, March 31st. This represents a $3.48 dividend on an annualized basis and a dividend yield of 1.30%.
UPDATE -- Apollo Funds to Acquire Majority Stake in Novolex
Becton, Dickinson and pays an annual dividend of $3.48 per share and currently has a dividend yield of 1.32%. Becton, Dickinson and has been increasing its dividend for 50 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Becton, Dickinson and is 60.21%.
Apollo Funds to Acquire Majority Stake in Novolex
A Leading Sustainable Packaging Provider Poised for Continued GrowthNEW YORK and HARTSVILLE, S.C., Feb.
